Tigermed Consulting Co., Ltd. closed a $5 million Series A financing from Qiming Venture Partners, a funding that ChinaBio® Today announced earlier. Tigermed, which proclaimed itself one of the largest CROs in China, said the funding would usher in a period of rapid expansion. In fact, the company said that the financing would be used in part to hire world class personnel, rather than the usual investment in facilities. More details...
Sorry... this feature or article is only available to subscribers.